alastair gray

Citada per

	Totes	Des de 2020
Citacions	53119	19348
Índex h	110	63
Índex i10	380	262

4100

2050

1025

3075

1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025179 249 376 430 482 575 568 684 836 995 1035 1098 1318 1514 1777 2381 2544 2764 2995 3020 3101 3460 3620 3922 4020 3790 3433 513

Accés públic

Mostra-ho tot

222 articles

10 articles

disponibles

no disponibles

Es basa en els requisits de les agències que proporcionen el finançament

Coautors

Borislava MihaylovaUniversity of Oxford, Queen Mary University of LondonCorreu electrònic verificat a dph.ox.ac.uk
Philip ClarkeProfessor of health economics, university of melbourneCorreu electrònic verificat a unimelb.edu.au
david p taggartProfessor of Cardiovascular Surgery Oxford UniversityCorreu electrònic verificat a ouh.nhs.uk
Marcus FlatherUniversity of East AngliaCorreu electrònic verificat a uea.ac.uk
Oliver Rivero-AriasAssociate Professor, University of OxfordCorreu electrònic verificat a npeu.ox.ac.uk
Andrew BriggsLondon School of Hygiene & Tropical MedicineCorreu electrònic verificat a lshtm.ac.uk
Umberto BenedettoUniversity of BristolCorreu electrònic verificat a bristol.ac.uk
Colin BaigentProfessor of Epidemiology, Oxford UniversityCorreu electrònic verificat a ctsu.ox.ac.uk
Helen A DakinHealth Economics Research Centre, University of Oxford, UKCorreu electrònic verificat a ndph.ox.ac.uk
Douglas G AltmanCentre for Statistics in Medicine, University of OxfordCorreu electrònic verificat a csm.ox.ac.uk
Mike RaynerProfessor of Population Health, University of OxfordCorreu electrònic verificat a dph.ox.ac.uk
Andrew FarmerProfessor of General Practice, University of OxfordCorreu electrònic verificat a phc.ox.ac.uk
a.mcguireProfessor of Health Economics, London School of EconomicsCorreu electrònic verificat a lse.ac.uk
Andrew J CarrNuffield Professor of Orthopaedic Surgery, University of OxfordCorreu electrònic verificat a ndorms.ox.ac.uk
Ray FitzpatrickUniversity of OxfordCorreu electrònic verificat a nuffield.ox.ac.uk
David J BeardUniversity of OxfordCorreu electrònic verificat a ndorms.ox.ac.uk
Peter RothwellUniversity of OxfordCorreu electrònic verificat a clneuro.ox.ac.uk
Peter ScarboroughUniversity of OxfordCorreu electrònic verificat a phc.ox.ac.uk
Nigel ArdenUniversity of OxfordCorreu electrònic verificat a ndorms.ox.ac.uk
Kamlesh KhuntiProfessor of Primary Care Diabetes and Vascular Medicine, University of LeicesterCorreu electrònic verificat a le.ac.uk

Segueix

alastair gray

Emeritus Professor of Health Economics, University of Oxford

Correu electrònic verificat a dph.ox.ac.uk

health economics


Títol Ordena per cites Ordena per any Ordena per títol	Citada per Citada per	Any
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials CT Trialists The Lancet 376 (9753), 1670-1681, 2010	4565*	2010
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ... Lancet (London, England) 380 (9841), 581-590, 2012	2421	2012
The economic burden of back pain in the UK N Maniadakis, A Gray Pain 84 (1), 95-103, 2000	2227	2000
Economic burden of cancer across the European Union: a population-based cost analysis R Luengo-Fernandez, J Leal, A Gray, R Sullivan The lancet oncology 14 (12), 1165-1174, 2013	1298	2013
Economic burden of cardiovascular diseases in the enlarged European Union J Leal, R Luengo-Fernández, A Gray, S Petersen, M Rayner European heart journal 27 (13), 1610-1619, 2006	1131	2006
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019	1022	2019
European cardiovascular disease statistics 2012 M Nichols, N Townsend, R Luengo-Fernandez, J Leal, A Gray, ...	1002	2012
Applied methods of cost-effectiveness analysis in healthcare AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth OUP Oxford, 2010	893	2010
European cardiovascular disease statistics S Allender, P Scarborough, V Peto, M Rayner, J Leal, ... European Heart Network 3, 11-35, 2008	873	2008
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ... Diabetologia 47, 1747-1759, 2004	797	2004
Knee replacement AJ Price, A Alvand, A Troelsen, JN Katz, G Hooper, A Gray, A Carr, ... The Lancet 392 (10158), 1672-1682, 2018	773	2018
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021	686*	2021
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62) P Clarke, A Gray, R Holman Medical Decision Making 22 (4), 340-349, 2002	620	2002
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial JN Primrose, R Perera, A Gray, P Rose, A Fuller, A Corkhill, S George, ... Jama 311 (3), 263-270, 2014	539	2014
European cardiovascular disease statistics J Leal, R Luengo-Fernandez, A Gray British Heart Foundation, 2000	521	2000
Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial DJ Beard, JL Rees, JA Cook, I Rombach, C Cooper, N Merritt, BA Shirkey, ... The Lancet 391 (10118), 329-338, 2018	514	2018
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom … AJ Hayes, J Leal, AM Gray, RR Holman, PM Clarke Diabetologia 56, 1925-1933, 2013	508	2013
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) A Gray, M Raikou, A McGuire, P Fenn, R Stevens, C Cull, I Stratton, ... Bmj 320 (7246), 1373-1378, 2000	490	2000
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open … PD Med Collaborative Group The Lancet 384 (9949), 1196-1205, 2014	474	2014
Handling uncertainty when performing economic evaluation of healthcare interventions. AH Briggs, AM Gray Health technology assessment (Winchester, England) 3 (2), 1-134, 1999	469	1999

En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.

Articles 1–20

Cites per any

Cites duplicades

Cites combinades

Addició de coautorsCoautors

Segueix

Citada per

Coautors